Lighthouse receives $49.2 million NIA grant to advance phase 2 study of Alzheimer’s disease
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
Guidelines aim to establish state-regulated veterinary blood banks
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
cSCC is one of the most common cancers in the U.S. and globally
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Subscribe To Our Newsletter & Stay Updated